{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T01:28:27Z","timestamp":1786670907255,"version":"build-2736575974"},"reference-count":365,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI007417-28"],"award-info":[{"award-number":["T32AI007417-28"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F32AI186453-01"],"award-info":[{"award-number":["F32AI186453-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013278","name":"EU Joint Programme Neurodegenerative Disease Research","doi-asserted-by":"publisher","award":["JPNDWG2021-012"],"award-info":[{"award-number":["JPNDWG2021-012"]}],"id":[{"id":"10.13039\/100013278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["L70AG084124-01"],"award-info":[{"award-number":["L70AG084124-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pharmr.2026.100113","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:24:43Z","timestamp":1769707483000},"page":"100113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1248-8221","authenticated-orcid":false,"given":"Michael","family":"Spedding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-497X","authenticated-orcid":false,"given":"Steve","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie-Ga\u00eblle","family":"Bellozzi Woestelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chiricozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Lledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-2537","authenticated-orcid":false,"given":"Rushika","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7614-0403","authenticated-orcid":false,"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Rene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"St Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1697","authenticated-orcid":false,"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Taquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-2119","authenticated-orcid":false,"given":"Michal","family":"Toborek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Gressens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6578","key":"10.1016\/j.pharmr.2026.100113_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib2","first-page":"160","article-title":"Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications","volume":"19","author":"Bjornevik","year":"2023","journal-title":"Nat Rev Neurol"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100113_bib3","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of postacute sequelae of SARS-CoV-2 infection","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib4","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","article-title":"The immunology of long COVID","volume":"23","author":"Altmann","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib5","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1002\/jmv.27878","article-title":"The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or post-COVID-19 syndrome","volume":"94","author":"Sivan","year":"2022","journal-title":"J Med Virol"},{"issue":"7862","key":"10.1016\/j.pharmr.2026.100113_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100113_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577658","article-title":"Neurological manifestations of COVID-19: a comprehensive literature review and discussion of mechanisms","volume":"358","author":"Johansson","year":"2021","journal-title":"J Neuroimmunol"},{"issue":"7907","key":"10.1016\/j.pharmr.2026.100113_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK Biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100113_bib9","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","article-title":"The neurobiology of long COVID","volume":"110","author":"Monje","year":"2022","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib10","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib12","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1038\/s41467-023-39973-6","article-title":"Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up","volume":"14","author":"Gr\u00f8nkj\u00e6r","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","volume":"30","author":"Cai","year":"2024","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S2215-0366(24)00214-1","article-title":"Cognitive and psychiatric symptom trajectories 2\u20133 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK","volume":"11","author":"Taquet","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad357","article-title":"Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury","volume":"6","author":"Taquet","year":"2024","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/jama.2024.11370","article-title":"Evidence mounts that about 7% of US adults have had long COVID","volume":"332","author":"Fang","year":"2024","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib17","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3390\/v16121955","article-title":"Persistence of long COVID symptoms two years after SARS-CoV-2 infection: a prospective longitudinal cohort study","volume":"16","author":"Joseph","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16181","article-title":"Cognitive domains affected post-COVID-19; a systematic review and meta-analysis","volume":"32","author":"Fanshawe","year":"2025","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.7326\/M24-0737","article-title":"Differentiation of prior SARS-CoV-2 infection and postacute sequelae by standard Clinical Laboratory measurements in the RECOVER cohort","volume":"177","author":"Erlandson","year":"2024","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.17440","article-title":"Epidemiologic features of recovery from SARS-CoV-2 infection","volume":"7","author":"Oelsner","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyad165","article-title":"Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study","volume":"53","author":"Elneima","year":"2024","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.pharmr.2026.100113_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbi.2023.05.014","article-title":"Risks of neurological and psychiatric sequelae 2 years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other causes","volume":"112","author":"Ley","year":"2023","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.pharmr.2026.100113_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101044","article-title":"Cognitive deficits in people who have recovered from COVID-19","volume":"39","author":"Hampshire","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa2311330","article-title":"Cognition and memory after Covid-19 in a large community sample","volume":"390","author":"Hampshire","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib25","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1093\/brain\/awac321","article-title":"Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses","volume":"145","author":"Needham","year":"2022","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib26","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S2666-7568(23)00187-3","article-title":"Cognitive decline in older adults in the UK during and after the COVID-19 pandemic: a longitudinal analysis of PROTECT study data","volume":"4","author":"Corbett","year":"2023","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib27","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1038\/s41467-023-42320-4","article-title":"Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses","volume":"14","author":"Michael","year":"2023","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib28","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMe2400189","article-title":"Long Covid and impaired cognition\u2014more evidence and more work to Do","volume":"390","author":"Al-Aly","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S2215-0366(22)00260-7","article-title":"Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients","volume":"9","author":"Taquet","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100113_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbi.2024.04.015","article-title":"Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures","volume":"119","author":"VanElzakker","year":"2024","journal-title":"Brain Behav Immun"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib31","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00221-024-06882-z","article-title":"Frontal-striatal glucose metabolism and fatigue in patients with multiple sclerosis, long COVID, and COVID-19 recovered controls","volume":"242","author":"Rudroff","year":"2024","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pharmr.2026.100113_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101896","article-title":"Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study","volume":"57","author":"McAuley","year":"2023","journal-title":"EClinicalmedicine"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2024.7452","article-title":"Severity and long-term mortality of COVID-19, influenza, and respiratory syncytial virus","volume":"185","author":"Bajema","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"7207","key":"10.1016\/j.pharmr.2026.100113_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bmj.319.7207.427","article-title":"Recovery from intensive care","volume":"319","author":"Griffiths","year":"1999","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1164\/rccm.202203-0564OC","article-title":"Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post-COVID-19 study","volume":"207","author":"Stewart","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pccm.2022.12.002","article-title":"Pulmonary fibrosis: a short- or long-term sequelae of severe COVID-19?","volume":"1","author":"Zheng","year":"2023","journal-title":"Chin Med J Pulm Crit Care Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13613-024-01293-3","article-title":"Pulmonary redox imbalance drives early fibroproliferative response in moderate\/severe coronavirus disease-19 acute respiratory distress syndrome and impacts long-term lung abnormalities","volume":"14","author":"Yang","year":"2024","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.32074\/1591-951X-954","article-title":"COVID-19. Biology, pathophysiology, and immunology: a pathologist view","volume":"115","author":"Chilosi","year":"2023","journal-title":"Pathologica"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1164\/rccm.202212-2314LE","article-title":"Novel insight into pulmonary fibrosis and long COVID","volume":"207","author":"Kamp","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib40","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s10787-022-01027-6","article-title":"Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals","volume":"30","author":"Al-Kuraishy","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib41","article-title":"Effectiveness and safety of pirfenidone and nintedanib for pulmonary fibrosis in COVID-19-induced severe pneumonia: an interventional study","volume":"14","author":"Choudhary","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pharmr.2026.100113_bib42","article-title":"Case report: pirfenidone in the treatment of post-COVID-19 pulmonary fibrosis","volume":"9","author":"Zhou","year":"2022","journal-title":"Front Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.medcli.2022.12.021","article-title":"Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: a randomized, prospective study","volume":"160","author":"Kerget","year":"2023","journal-title":"Med Clin"},{"key":"10.1016\/j.pharmr.2026.100113_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107362","article-title":"Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy","volume":"217","author":"Sansores","year":"2023","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14656566.2024.2438322","article-title":"Tackling pulmonary fibrosis risks in post-COVID-19: cutting-edge treatments","volume":"26","author":"Duong-Quy","year":"2025","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1148\/radiol.220069","article-title":"Lung abnormalities detected with hyperpolarized 129Xe MRI in patients with long COVID","volume":"305","author":"Grist","year":"2022","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib47","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/s24041250","article-title":"Ebbing strength, fading power: unveiling the impact of persistent fatigue on muscle performance in COVID-19 survivors","volume":"24","author":"Kowal","year":"2024","journal-title":"Sensors"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/biomedicines12020460","article-title":"Muscle dysfunction and functional status in COVID-19 patients during illness and after hospital discharge","volume":"12","author":"Psenicka","year":"2024","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib49","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1152\/japplphysiol.00497.2022","article-title":"Lactate as a myokine and exerkine: drivers and signals of physiology and metabolism","volume":"134","author":"Brooks","year":"2023","journal-title":"J Appl Physiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1164\/rccm.202108-1903LE","article-title":"Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome","volume":"205","author":"de Boer","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib51","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/metabo12111026","article-title":"Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC)","volume":"12","author":"Guntur","year":"2022","journal-title":"Metabolites"},{"issue":"596","key":"10.1016\/j.pharmr.2026.100113_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf8396","article-title":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"de Melo","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib53","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1038\/s41467-023-40228-7","article-title":"Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants","volume":"14","author":"de Melo","year":"2023","journal-title":"Nat Commun"},{"issue":"7941","key":"10.1016\/j.pharmr.2026.100113_bib54","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib55","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1038\/s41380-022-01831-0","article-title":"SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein","volume":"28","author":"Albornoz","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100113_bib56","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.virol.2015.02.038","article-title":"Viral activation of cellular metabolism","volume":"479\u2013480","author":"Sanchez","year":"2015","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4149\/av_2020_210","article-title":"Metabolic reprogramming as a feast for virus replication","volume":"64","author":"Polcicova","year":"2020","journal-title":"Acta Virol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib58","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1473-3099(24)00171-3","article-title":"The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China","volume":"24","author":"Zuo","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.pharmr.2026.100113_bib59","article-title":"Relationship between acute SARS-CoV-2 viral clearance with long COVID symptoms: a cohort study","author":"Herbert","year":"2024","journal-title":"Preprint"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib60","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.cmi.2024.07.006","article-title":"The efficacy of antivirals, corticosteroids, and mAbs as acute COVID treatments in reducing the incidence of long COVID: a systematic review and meta-analysis","volume":"30","author":"Sun","year":"2024","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib61","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/alr.23612","article-title":"Paxlovid is associated with lower rates of long COVID-19 smell and taste disorders","volume":"15","author":"Wang","year":"2025","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70351","article-title":"Long-term stroke and mortality risk reduction associated with acute-phase Paxlovid use in mild-to-moderate COVID-19","volume":"97","author":"Chuang","year":"2025","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib63","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","article-title":"Nirmatrelvir-Ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial","volume":"184","author":"Geng","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib64","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1473-3099(25)00073-8","article-title":"Nirmatrelvir\u2013ritonavir versus placebo\u2013ritonavir in individuals with long COVID in the USA (Pax LC): a double-blind, randomised, placebo-controlled, phase 2, decentralised trial","volume":"25","author":"Sawano","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"7985","key":"10.1016\/j.pharmr.2026.100113_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing features of long COVID identified through immune profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib66","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11606-024-09290-9","article-title":"Incidence and prevalence of post-COVID-19 myalgic encephalomyelitis: a report from the observational RECOVER-adult study","volume":"40","author":"Vernon","year":"2025","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pharmr.2026.100113_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1090747","article-title":"Myalgic encephalomyelitis\/chronic fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic","volume":"14","author":"Bonilla","year":"2023","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib68","first-page":"1","article-title":"Chronic fatigue syndrome and mitochondrial dysfunction","volume":"2","author":"Myhill","year":"2009","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib69","first-page":"1","article-title":"Targeting mitochondrial dysfunction in the treatment of Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)\u2014a clinical audit","volume":"6","author":"Myhill","year":"2013","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib70","first-page":"208","article-title":"Mitochondrial dysfunction and the pathophysiology of Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"5","author":"Booth","year":"2012","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/biom15030357","article-title":"Unravelling the connection between energy metabolism and immune senescence\/exhaustion in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"15","author":"Van Campenhout","year":"2025","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib72","article-title":"Causes of symptoms and symptom persistence in long COVID and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"6","author":"Komaroff","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.pharmr.2026.100113_bib73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbi.2017.02.009","article-title":"Neural consequences of post-exertion malaise in Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"62","author":"Cook","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib74","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00421-025-05759-5","article-title":"Physical function and psychosocial outcomes after a 6-month self-paced aquatic exercise program for individuals with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"125","author":"Broadbent","year":"2025","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.pharmr.2026.100113_bib75","article-title":"Improvement of long COVID symptoms over one year","volume":"9","author":"Oliveira","year":"2022","journal-title":"Front Med"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100113_bib76","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.3390\/ijms23147906","article-title":"Metabolomic evidence for peroxisomal dysfunction in myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"23","author":"Che","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"37","key":"10.1016\/j.pharmr.2026.100113_bib77","doi-asserted-by":"crossref","first-page":"E5472","DOI":"10.1073\/pnas.1607571113","article-title":"Metabolic features of chronic fatigue syndrome","volume":"113","author":"Naviaux","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib78","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s44321-025-00258-8","article-title":"Replicated blood-based biomarkers for myalgic encephalomyelitis not explicable by inactivity","volume":"17","author":"Beentjes","year":"2025","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55473-4","article-title":"Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"9","author":"Ghali","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.anai.2024.08.021","article-title":"Inflammatory pathways in patients with post-acute sequelae of COVID-19: the role of the clinical immunologist","volume":"133","author":"Elliott","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib81","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Rep Med"},{"issue":"6684","key":"10.1016\/j.pharmr.2026.100113_bib82","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.abn1034","article-title":"Decoding the autoantibody reactome","volume":"383","author":"Jaycox","year":"2024","journal-title":"Science"},{"issue":"8035","key":"10.1016\/j.pharmr.2026.100113_bib83","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41586-024-07926-8","article-title":"An aberrant immune\u2013epithelial progenitor niche drives viral lung sequelae","volume":"634","author":"Narasimhan","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib84","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41591-023-02525-y","article-title":"Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization","volume":"29","author":"Taquet","year":"2023","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.pharmr.2026.100113_bib85","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3390\/cells12182270","article-title":"Biomarkers of neurological damage: from acute stage to post-acute sequelae of COVID-19","volume":"12","author":"Zingaropoli","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100113_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1480438","article-title":"The role of interferon signaling in neurodegeneration and neuropsychiatric disorders","volume":"15","author":"Sirkis","year":"2024","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib87","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered lipid metabolism in recovered SARS patients twelve years after infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib88","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqac002","article-title":"Is \u201cLong Covid\u201d similar to \u201cLong SARS\u201d","volume":"3","author":"Patcai","year":"2022","journal-title":"Oxf Open Immunol"},{"key":"10.1016\/j.pharmr.2026.100113_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110702","article-title":"Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"201","author":"Chaves-Filho","year":"2023","journal-title":"Brain Res Bull"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib90","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(23)00684-9","article-title":"Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study","volume":"24","author":"Xie","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib91","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/vaccines12070790","article-title":"Clinical and diagnostic features of post-acute COVID-19 vaccination syndrome (PACVS)","volume":"12","author":"Mundorf","year":"2024","journal-title":"Vaccines"},{"issue":"8080","key":"10.1016\/j.pharmr.2026.100113_bib92","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-025-09332-0","article-title":"Respiratory viral infections awaken metastatic breast cancer cells in lungs","volume":"645","author":"Chia","year":"2025","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100113_bib93","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.cell.2025.04.007","article-title":"Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cells","volume":"188","author":"Morrison","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib94","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-025-02413-6","article-title":"UGCG and the glycosphingolipid rheostat: a metabolic checkpoint governing immune activation and tumor immune evasion","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100113_bib95","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1111\/bph.15094","article-title":"A rational road map for SARS-CoV-2\/COVID-19 pharmacotherapeutic research and development","volume":"177","author":"Alexander","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"6\u20137","key":"10.1016\/j.pharmr.2026.100113_bib96","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1515\/hsz-2014-0273","article-title":"Sphingolipids in viral infection","volume":"396","author":"Schneider-Schaulies","year":"2015","journal-title":"Biol Chem"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib97","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3390\/cells10092175","article-title":"Sphingolipids: effectors and Achilles heals in viral infections?","volume":"10","author":"Schneider-Schaulies","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib98","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib99","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/glycob\/4.6.759","article-title":"A calculation of all possible oligosaccharide isomers both branched and linear yields 1.05 x 10(12) structures for a reducing hexasaccharide: the isomer Barrier to development of single-method saccharide sequencing or synthesis systems","volume":"4","author":"Laine","year":"1994","journal-title":"Glycobiology"},{"key":"10.1016\/j.pharmr.2026.100113_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.572965","article-title":"Gangliosides in the brain: physiology, pathophysiology and therapeutic applications","volume":"14","author":"Sipione","year":"2020","journal-title":"Front Neurosci"},{"issue":"27","key":"10.1016\/j.pharmr.2026.100113_bib101","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1021\/ja9813055","article-title":"Spontaneous hydrolysis of glycosides","volume":"120","author":"Wolfenden","year":"1998","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib102","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1021\/acs.accounts.2c00804","article-title":"The road to quantitative lipid biochemistry in living cells","volume":"56","author":"Iglesias-Artola","year":"2023","journal-title":"Acc Chem Res"},{"issue":"2\u20133","key":"10.1016\/j.pharmr.2026.100113_bib103","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/07328303.2022.2063308","article-title":"The structural diversity of natural glycosphingolipids (GSLs)","volume":"41","author":"Guo","year":"2022","journal-title":"J Carbohydr Chem"},{"key":"10.1016\/j.pharmr.2026.100113_bib104","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.plipres.2016.03.006","article-title":"The enigma of ceramide synthase regulation in mammalian cells","volume":"63","author":"Wegner","year":"2016","journal-title":"Prog Lipid Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00018-018-2984-8","article-title":"The role of dihydrosphingolipids in disease","volume":"76","author":"Magaye","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100113_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413184","article-title":"Ceramide transfer protein (CERT): an overlooked molecular player in cancer","volume":"22","author":"Chung","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib107","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.3390\/ijms24119558","article-title":"Ganglioside GM1 and the central nervous system","volume":"24","author":"Guo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100113_bib108","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4684-7844-0_2","article-title":"Ganglioside designation","volume":"125","author":"Svennerholm","year":"1980","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib109","doi-asserted-by":"crossref","first-page":"6312","DOI":"10.3390\/ijms25126312","article-title":"Sphingolipids: less enigmatic but still many questions about the Role(s) of ceramide in the synthesis\/function of the ganglioside class of glycosphingolipids","volume":"25","author":"Schengrund","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7158","key":"10.1016\/j.pharmr.2026.100113_bib110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature06097","article-title":"Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide","volume":"449","author":"D\u2019Angelo","year":"2007","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100113_bib111","first-page":"74","article-title":"On the isolation and characterization of N-acetyl-sialic acid","volume":"61","author":"Svennerholm","year":"1956","journal-title":"Acta Soc Med Ups"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib112","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/omi.2009.0148","article-title":"The Sialome\u2014far more than the sum of its parts","volume":"14","author":"Cohen","year":"2010","journal-title":"OMICS A J Integr Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib113","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/glycob\/cwac072","article-title":"Cataloging natural sialic acids and other nonulosonic acids (NulOs), and their representation using the Symbol Nomenclature for Glycans","volume":"33","author":"Lewis","year":"2023","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib114","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41589-021-00924-1","article-title":"Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2","volume":"18","author":"Nguyen","year":"2022","journal-title":"Nat Chem Biol"},{"issue":"suppl 2","key":"10.1016\/j.pharmr.2026.100113_bib115","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1073\/pnas.0914634107","article-title":"Colloquium paper: uniquely human evolution of sialic acid genetics and biology","volume":"107","author":"Varki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib116","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/ijms21030868","article-title":"GM1 ganglioside is A key factor in maintaining the mammalian neuronal functions avoiding neurodegeneration","volume":"21","author":"Chiricozzi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib117","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1002\/2211-5463.13727","article-title":"GM1 ganglioside exerts protective effects against glutamate-excitotoxicity via its oligosaccharide in wild-type and amyotrophic lateral sclerosis motor neurons","volume":"13","author":"Lunghi","year":"2023","journal-title":"FEBS Open Bio"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib118","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pharmr.2026.100113_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2025.109469","article-title":"Human-specific evolutionary genetic loss of addition of a single oxygen atom from sialic acids increases hydrophobicity of cells and proteins","volume":"552","author":"Dunker","year":"2025","journal-title":"Carbohydr Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib120","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1152\/physrev.00040.2021","article-title":"Comparative physiological anthropogeny: exploring molecular underpinnings of distinctly human phenotypes","volume":"103","author":"Vaill","year":"2023","journal-title":"Physiol Rev"},{"issue":"1886","key":"10.1016\/j.pharmr.2026.100113_bib121","article-title":"Human-like Cmah inactivation in mice increases running endurance and decreases muscle fatigability: implications for human evolution","volume":"285","author":"Okerblom","year":"2018","journal-title":"Proc Biol Sci"},{"issue":"7015","key":"10.1016\/j.pharmr.2026.100113_bib122","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature03052","article-title":"Endurance running and the evolution of Homo","volume":"432","author":"Bramble","year":"2004","journal-title":"Nature"},{"issue":"7407","key":"10.1016\/j.pharmr.2026.100113_bib123","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/487295a","article-title":"Olympics: run for your life","volume":"487","author":"Noakes","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib124","first-page":"822","article-title":"The story of the human body: evolution, health and disease","volume":"48","author":"Lieberman","year":"2016","journal-title":"Fam Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001871","article-title":"Exceptional evolutionary divergence of human muscle and brain metabolomes parallels human cognitive and physical uniqueness","volume":"12","author":"Bozek","year":"2014","journal-title":"PLoS Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib126","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/2211-5463.13612","article-title":"Lipid rafts and human diseases: why we need to target gangliosides","volume":"13","author":"Fantini","year":"2023","journal-title":"FEBS Open Bio"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100113_bib127","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.3390\/ijms25168583","article-title":"Glutamate, gangliosides, and the synapse: electrostatics at work in the brain","volume":"25","author":"Chahinian","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100113_bib128","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/bs.apcsb.2021.08.003","article-title":"Ganglioside binding domains in proteins: physiological and pathological mechanisms","volume":"128","author":"Azzaz","year":"2022","journal-title":"Adv Protein Chem Struct Biol"},{"key":"10.1016\/j.pharmr.2026.100113_bib129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fphar.2019.00883","article-title":"Ambroxol hydrochloride improves motor functions and extends survival in a mouse model of familial amyotrophic lateral sclerosis","volume":"10","author":"Bouscary","year":"2019","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183496","article-title":"\u03b2-glucosylation of cholesterol reduces sterol-sphingomyelin interactions","volume":"1863","author":"Hanashima","year":"2021","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100113_bib131","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1074\/jbc.RA119.012502","article-title":"Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol","volume":"295","author":"Akiyama","year":"2020","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib132","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3390\/ijms24021760","article-title":"AmyP53 prevents the formation of neurotoxic \u03b2-amyloid oligomers through an Unprecedent mechanism of interaction with gangliosides: insights for Alzheimer\u2019s disease therapy","volume":"24","author":"Azzaz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100113_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110384","article-title":"Structural basis of botulinum neurotoxin serotype A1 binding to human SV2A or SV2C receptors","volume":"373","author":"Azzaz","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharmr.2026.100113_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.cplett.2022.140260","article-title":"Identification of possible binding modes of SARS-CoV-2 spike N-terminal domain for ganglioside GM1","volume":"812","author":"Das","year":"2023","journal-title":"Chem Phys Lett"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104763","article-title":"The role of high cholesterol in SARS-CoV-2 infectivity","volume":"299","author":"Wang","year":"2023","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102570","article-title":"The ganglioside GM1a functions as a coreceptor\/attachment factor for dengue virus during infection","volume":"298","author":"Tantirimudalige","year":"2022","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105960","article-title":"Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection","volume":"55","author":"Fantini","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib138","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1021\/acsinfecdis.3c00106","article-title":"SARS-CoV-2 binding to terminal sialic acid of gangliosides embedded in lipid membranes","volume":"9","author":"Negi","year":"2023","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.pharmr.2026.100113_bib139","article-title":"Sialic acid-dependent binding and viral entry of SARS-CoV-2","author":"Nguyen","year":"2021","journal-title":"Preprint"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib140","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/iai.8.6.851-859.1973","article-title":"Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid","volume":"8","author":"Holmgren","year":"1973","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib141","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1073\/pnas.72.7.2520","article-title":"Interaction of cholera toxin and membrane GM1 ganglioside of small intestine","volume":"72","author":"Holmgren","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib142","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/ja0378207","article-title":"Dissecting the cholera toxin-ganglioside GM1 interaction by isothermal titration calorimetry","volume":"126","author":"Turnbull","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib143","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/pro.5560030202","article-title":"Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide","volume":"3","author":"Merritt","year":"1994","journal-title":"Protein Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006862","article-title":"GM1 ganglioside-independent intoxication by cholera toxin","volume":"14","author":"Cervin","year":"2018","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/glycob\/cwad069","article-title":"Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands","volume":"33","author":"Singla","year":"2023","journal-title":"Glycobiology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib146","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41589-024-01748-5","article-title":"Fucosylation of glycoproteins and glycolipids: opposing roles in cholera intoxication","volume":"21","author":"Ghorashi","year":"2025","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.pharmr.2026.100113_bib147","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.09545","article-title":"Fucosylation and protein glycosylation create functional receptors for cholera toxin","volume":"4","author":"Wands","year":"2015","journal-title":"eLife"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100113_bib148","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1158\/1078-0432.CCR-18-0018","article-title":"A novel, fully human anti\u2013fucosyl-GM1 antibody demonstrates potent in vitro and in vivo antitumor activity in preclinical models of small cell lung cancer","volume":"24","author":"Ponath","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib149","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/glycob\/cws115","article-title":"Glycosphingolipid composition of epithelial cells isolated along the villus axis of small intestine of a single human individual","volume":"22","author":"Breimer","year":"2012","journal-title":"Glycobiology"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib150","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1471-4159.1992.tb11018.x","article-title":"Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda Equina","volume":"59","author":"Ogawa-Goto","year":"1992","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib151","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1471-4159.1973.tb07527.x","article-title":"Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component","volume":"21","author":"Ledeen","year":"1973","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib152","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1096\/fj.201601299R","article-title":"Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides","volume":"31","author":"Pan","year":"2017","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib153","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1073\/pnas.73.4.1034","article-title":"Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness","volume":"73","author":"Moss","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib154","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/glycob\/cwab063","article-title":"Are sialic acids involved in COVID-19 pathogenesis?","volume":"31","author":"Dhar","year":"2021","journal-title":"Glycobiology"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib155","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/glycob\/cwab032","article-title":"The role of cell surface sialic acids for SARS-CoV-2 infection","volume":"31","author":"Sun","year":"2021","journal-title":"Glycobiology"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib156","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3390\/v15091854","article-title":"Host membranes as drivers of virus evolution","volume":"15","author":"Matveeva","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib157","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in Synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib158","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50020-7","article-title":"Mixing brain cerebrosides with brain ceramides, cholesterol and phospholipids","volume":"9","author":"Gonz\u00e1lez-Ram\u00edrez","year":"2019","journal-title":"Sci Rep"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100113_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910198","article-title":"Severity of COVID-19 patients predicted by serum sphingolipids signature","volume":"22","author":"Torretta","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib161","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/biom14030296","article-title":"Association of altered plasma lipidome with disease severity in COVID-19 patients","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100860","article-title":"Integrated lipidomic and proteomic profiling reveals metabolic network disruption by SARS-CoV-2 variants","volume":"66","author":"Farley","year":"2025","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib163","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11306-024-02195-y","article-title":"Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers","volume":"21","author":"Sun","year":"2024","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib164","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12967-024-05422-1","article-title":"Targeted metabolomics identifies accurate CSF metabolite biomarkers for the differentiation between COVID-19 with neurological involvement and CNS infections with neurotropic viral pathogens","volume":"22","author":"Neu","year":"2024","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.32607\/actanaturae.27400","article-title":"Ceramides as potential new predictors of the severity of acute coronary syndrome in conjunction with SARS-CoV-2 infection","volume":"16","author":"Lozhkina","year":"2024","journal-title":"Acta Nat"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib166","article-title":"Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility","volume":"13","author":"Alb\u00f3niga","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100113_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114827","article-title":"Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)","volume":"217","author":"Ciccarelli","year":"2022","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00755-z","article-title":"Link between serum lipid signature and prognostic factors in COVID-19 patients","volume":"11","author":"Dei Cas M","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00286-7","article-title":"Inferring a causal relationship between ceramide levels and COVID-19 respiratory distress","volume":"11","author":"Khodadoust","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100113_bib170","article-title":"Evidence for peroxisomal dysfunction and dysregulation of the CDP-choline pathway in myalgic encephalomyelitis\/chronic fatigue syndrome","author":"Che","year":"2022","journal-title":"Preprint"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib171","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s43587-022-00309-6","article-title":"Sphingolipids accumulate in aged muscle, and their reduction counteracts sarcopenia","volume":"2","author":"Laurila","year":"2022","journal-title":"Nat Aging"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100113_bib172","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.cell.2023.06.005","article-title":"TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry","volume":"186","author":"Baggen","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib173","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s42003-024-06810-5","article-title":"Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism","volume":"7","author":"Takahashi","year":"2024","journal-title":"Commun Biol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib174","doi-asserted-by":"crossref","first-page":"e00017","DOI":"10.1128\/JVI.00017-19","article-title":"Glucosylceramidase maintains influenza virus infection by regulating endocytosis","volume":"93","author":"Drews","year":"2019","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228735","article-title":"Glucosylceramide synthase maintains influenza virus entry and infection","volume":"15","author":"Drews","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmr.2026.100113_bib176","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2022.03.014","article-title":"Modulation of Zika virus replication via glycosphingolipids","volume":"572","author":"Konan","year":"2022","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib177","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/v14112566","article-title":"Cell type variability in the incorporation of lipids in the dengue virus Virion","volume":"14","author":"Hitakarun","year":"2022","journal-title":"Viruses"},{"issue":"7997","key":"10.1016\/j.pharmr.2026.100113_bib178","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41586-023-06956-y","article-title":"Motion of VAPB molecules reveals ER-mitochondria contact site subdomains","volume":"626","author":"Obara","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib179","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1069","article-title":"Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19","volume":"12","author":"Kurano","year":"2022","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib180","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2023.2200847","article-title":"A platelet lipidomics signature in patients with COVID-19","volume":"34","author":"Goracci","year":"2023","journal-title":"Platelets"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100113_bib181","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1007\/s00216-023-04825-1","article-title":"Characterization of the cellular lipid composition during SARS-CoV-2 infection","volume":"415","author":"Abdel-Megied","year":"2023","journal-title":"Anal Bioanal Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100208","article-title":"The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses","volume":"63","author":"Saud","year":"2022","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib183","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.201108175","article-title":"Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane","volume":"196","author":"Gerl","year":"2012","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib184","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39049-x","article-title":"The plasma metabolome of long COVID patients two years after infection","volume":"13","author":"L\u00f3pez-Hern\u00e1ndez","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006853","article-title":"Dynamic remodeling of lipids coincides with dengue virus replication in the midgut of Aedes aegypti mosquitoes","volume":"14","author":"Chotiwan","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib186","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02929-1","article-title":"Flavivirus infections induce a Golgi stress response in vertebrate and mosquito cells","volume":"11","author":"Viettri","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib187","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02609-23","article-title":"The ER-Golgi transport of influenza virus through NS1-Sec13 association during virus replication","volume":"12","author":"Chua","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.pharmr.2026.100113_bib188","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.omtn.2021.12.034","article-title":"SARS-CoV-2 causes a significant stress response mediated by small RNAs in the blood of COVID-19 patients","volume":"27","author":"Liu","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib189","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.chom.2020.11.003","article-title":"Integrative imaging reveals SARS-CoV-2-Induced reshaping of subcellular morphologies","volume":"28","author":"Cortese","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pharmr.2026.100113_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.794264","article-title":"Imaging techniques: essential tools for the study of SARS-CoV-2 infection","volume":"12","author":"Deroubaix","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"7963","key":"10.1016\/j.pharmr.2026.100113_bib191","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41586-023-06050-3","article-title":"In situ architecture of the ER-mitochondria encounter structure","volume":"618","author":"Wozny","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib192","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0021-9258(18)52406-6","article-title":"Newly made phosphatidylserine and phosphatidylethanolamine are preferentially translocated between rat liver mitochondria and endoplasmic reticulum","volume":"266","author":"Vance","year":"1991","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib193","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/bj3310217","article-title":"A mitochondrial membrane protein is required for translocation of phosphatidylserine from mitochondria-associated membranes to mitochondria","volume":"331","author":"Shiao","year":"1998","journal-title":"Biochem J"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib194","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax8352","article-title":"Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity","volume":"5","author":"Heden","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2026.100113_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.653688","article-title":"The role of mitochondrial dysfunction and ER stress in TDP-43 and C9ORF72 ALS","volume":"15","author":"Dafinca","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib196","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1194\/jlr.R084004","article-title":"Historical perspective: phosphatidylserine and phosphatidylethanolamine from the 1800s to the present","volume":"59","author":"Vance","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmr.2026.100113_bib197","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","article-title":"Phosphatidylethanolamine metabolism in health and disease","volume":"321","author":"Calzada","year":"2016","journal-title":"Int Rev Cell Mol Biol"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100113_bib198","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112542","article-title":"Coronaviral ORF6 protein mediates inter-organelle contacts and modulates host cell lipid flux for virus production","volume":"42","author":"Yue","year":"2023","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib199","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0005-2760(76)90082-5","article-title":"Phospholipids of Semliki Forest virus grown in cultured mosquito cells","volume":"450","author":"Luukkonen","year":"1976","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/ijp.ijp_442_21","article-title":"Aging, VO2 max, entropy, and COVID-19","volume":"54","author":"Spedding","year":"2022","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100113_bib201","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13690-019-0375-8","article-title":"The age-performance relationship in the general population and strategies to delay age related decline in performance","volume":"77","author":"Berthelot","year":"2019","journal-title":"Arch Public Health"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0030220","article-title":"Entropy explains aging, genetic determinism explains longevity, and undefined terminology explains misunderstanding both","volume":"3","author":"Hayflick","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/j.pharmr.2026.100113_bib203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1395.001","article-title":"Biological aging is no longer an unsolved problem","volume":"1100","author":"Hayflick","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmr.2026.100113_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102400","article-title":"Long COVID as a disease of accelerated biological aging: an opportunity to translate geroscience interventions","volume":"99","author":"Shafqat","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib205","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1016\/S2666-7568(22)00245-8","article-title":"Long COVID and older people","volume":"3","author":"Mansell","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100113_bib206","doi-asserted-by":"crossref","first-page":"866","DOI":"10.15585\/mmwr.mm7232a3","article-title":"Long COVID and significant activity limitation among adults, by age\u2014United States, June 1\u201313, 2022, to June 7\u201319, 2023","volume":"72","author":"Ford","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib207","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.arr.2012.01.007","article-title":"Evolutionary aspects of human exercise\u2014born to run purposefully","volume":"11","author":"Mattson","year":"2012","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2220\/biomedres.45.163","article-title":"Effects of inactivity and exercise intervention on brain-derived neurotrophic factor in mice: comparison of kinetics in serum, skeletal muscle, and brain","volume":"45","author":"Miki","year":"2024","journal-title":"Biomed Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib209","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1460-9568.2004.03578.x","article-title":"BDNF increases rat brain mitochondrial respiratory coupling at complex I, but not complex II","volume":"20","author":"Markham","year":"2004","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib210","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1460-9568.2011.07965.x","article-title":"Brain-derived neurotrophic factor-mediated effects on mitochondrial respiratory coupling and neuroprotection share the same molecular signalling pathways","volume":"35","author":"Markham","year":"2012","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib211","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10298420290015836","article-title":"Gangliosides prevent excitotoxicity through activation of TrkB receptor","volume":"4","author":"Bachis","year":"2002","journal-title":"Neurotox Res"},{"issue":"7\u20138","key":"10.1016\/j.pharmr.2026.100113_bib212","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neuropharm.2010.10.012","article-title":"Exogenous gangliosides increase the release of brain-derived neurotrophic factor","volume":"60","author":"Lim","year":"2011","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib213","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw046","article-title":"Antidepressant-like effects of GM1 ganglioside involving the BDNF signaling cascade in mice","volume":"19","author":"Jiang","year":"2016","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pharmr.2026.100113_bib214","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fneur.2019.00859","article-title":"Gangliosides: treatment avenues in neurodegenerative disease","volume":"10","author":"Magistretti","year":"2019","journal-title":"Front Neurol"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100113_bib215","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/cells14211734","article-title":"Does amyotrophic lateral sclerosis (ALS) have metabolic causes from human evolution?","volume":"14","author":"Spedding","year":"2025","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib216","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10522-019-09837-y","article-title":"d-Galactose-induced accelerated aging model: an overview","volume":"20","author":"Azman","year":"2019","journal-title":"Biogerontology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib217","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1538\/expanim.20-0095","article-title":"Features of T-cell subset composition in a D-galactose-induced senescence mouse model","volume":"70","author":"Kawata","year":"2021","journal-title":"Exp Anim"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib218","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-82584-4","article-title":"Effects of a symptom-titrated exercise program on fatigue and quality of life in people with post-COVID condition\u2014a randomized controlled trial","volume":"14","author":"Barz","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100113_bib219","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fcimb.2020.00375","article-title":"Senescence in monocytes facilitates dengue virus infection by increasing infectivity","volume":"10","author":"Hsieh","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"7884","key":"10.1016\/j.pharmr.2026.100113_bib220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03995-1","article-title":"Virus-induced senescence is driver and therapeutic target in COVID-19","volume":"599","author":"Lee","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib221","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02951-2021","article-title":"Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis","volume":"60","author":"Evangelou","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmr.2026.100113_bib222","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1229098","article-title":"Contribution of viral and bacterial infections to senescence and immunosenescence","volume":"13","author":"Reyes","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib223","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13148-024-01724-9","article-title":"Epigenetic patterns, accelerated biological aging, and enhanced epigenetic drift detected 6 months following COVID-19 infection: insights from a genome-wide DNA methylation study","volume":"16","author":"Calzari","year":"2024","journal-title":"Clin Epigenet"},{"issue":"7992","key":"10.1016\/j.pharmr.2026.100113_bib224","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41586-023-06783-1","article-title":"CHIT1-positive microglia drive motor neuron ageing in the primate spinal cord","volume":"624","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib225","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/acn3.51890","article-title":"Proteomics and mathematical modeling of longitudinal CSF differentiates fast versus slow ALS progression","volume":"10","author":"Vu","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib226","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12974-020-01909-y","article-title":"Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation","volume":"17","author":"Varghese","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib227","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.neurobiolaging.2013.11.025","article-title":"Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis","volume":"35","author":"Allen","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib228","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12979-023-00406-z","article-title":"Accelarated immune ageing is associated with COVID-19 disease severity","volume":"21","author":"Lord","year":"2024","journal-title":"Immun Ageing"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib229","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1874609816666221228103320","article-title":"COVID-19 and brain aging: what are the implications of immunosenescence?","volume":"16","author":"Keller","year":"2023","journal-title":"Curr Aging Sci"},{"key":"10.1016\/j.pharmr.2026.100113_bib230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1298004","article-title":"From aging to long COVID: exploring the convergence of immunosenescence, inflammaging, and autoimmunity","volume":"14","author":"M\u00fcller","year":"2023","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib231","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1007\/s11357-024-01227-8","article-title":"Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults","volume":"46","author":"Russell","year":"2024","journal-title":"GeroScience"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib232","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study","volume":"13","author":"Al-Chalabi","year":"2014","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib233","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10312","article-title":"Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis","volume":"52","author":"Cutler","year":"2002","journal-title":"Ann Neurol"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100113_bib234","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1093\/hmg\/ddv439","article-title":"Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase","volume":"24","author":"Henriques","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib235","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1038\/s41598-017-05313-0","article-title":"Inhibition of \u03b2-glucocerebrosidase activity preserves motor unit integrity in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Henriques","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100113_bib236","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fnmol.2017.00433","article-title":"Sphingolipid metabolism is dysregulated at transcriptomic and metabolic levels in the spinal cord of an animal model of amyotrophic lateral sclerosis","volume":"10","author":"Henriques","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pharmr.2026.100113_bib237","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semcdb.2020.10.008","article-title":"Sphingolipids metabolism alteration in the central nervous system: amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases","volume":"112","author":"Bouscary","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.pharmr.2026.100113_bib238","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fnmol.2017.00356","article-title":"Lipid involvement in neurodegenerative diseases of the motor system: insights from lysosomal storage diseases","volume":"10","author":"Dodge","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"26","key":"10.1016\/j.pharmr.2026.100113_bib239","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1073\/pnas.1508767112","article-title":"Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis","volume":"112","author":"Dodge","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib240","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/bmb\/ldv022","article-title":"The genetics of Parkinson\u2019s disease","volume":"114","author":"Mullin","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.pharmr.2026.100113_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105663","article-title":"Glucocerebrosidase-associated Parkinson disease: pathogenic mechanisms and potential drug treatments","volume":"166","author":"Gegg","year":"2022","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib242","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JPD-171092","article-title":"Glucocerebrosidase mutations in Parkinson disease","volume":"7","author":"O\u2019Regan","year":"2017","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib243","article-title":"Gangliosides as therapeutic targets for neurodegenerative diseases","volume":"2024","author":"Inci","year":"2024","journal-title":"J Lipids"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib244","article-title":"Circulating sphingolipids in relation to cognitive decline and incident dementia: the cardiovascular Health Study","volume":"16","author":"Moseholm","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmr.2026.100113_bib245","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106798","article-title":"Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer\u2019s disease","volume":"205","author":"Wang","year":"2025","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib246","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.pharmr.2026.100113_bib247","article-title":"Profound lipid dysregulation in mutant TDP-43 mice is ameliorated by the glucocerebrosidase 2 inhibitor ambroxol","author":"Luikinga","year":"2022","journal-title":"Preprint"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib248","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/00207450590522847","article-title":"Lactate stress testing in sporadic amyotrophic lateral sclerosis","volume":"115","author":"Finsterer","year":"2005","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib249","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/0366-6999.172561","article-title":"Elimination rate of serum lactate is correlated with amyotrophic lateral sclerosis progression","volume":"129","author":"Zhang","year":"2016","journal-title":"Chin Med J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib250","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1038\/s41598-017-02811-z","article-title":"Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in amyotrophic lateral sclerosis during exercise","volume":"7","author":"Lanfranconi","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100113_bib251","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cnp.2025.05.001","article-title":"Neurophysiology and muscle histopathology in ICU-acquired muscle weakness: lessons learned from COVID-19","volume":"10","author":"Hejb\u00f8l","year":"2025","journal-title":"Clin Neurophysiol Pract"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib252","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13195-024-01593-7","article-title":"Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study","volume":"16","author":"G\u00f6tze","year":"2024","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib253","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10072-025-07994-2","article-title":"Tofersen for SOD1 amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"46","author":"Hamad","year":"2025","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib254","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s42466-023-00277-1","article-title":"No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache","volume":"5","author":"de Boni","year":"2023","journal-title":"Neurol Res Pract"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100113_bib255","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/diagnostics13132167","article-title":"Concentrations of serum brain injury biomarkers following SARS-CoV-2 infection in individuals with and without long-COVID-results from the prospective population-based COVI-GAPP study","volume":"13","author":"Telser","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib256","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1038\/s41598-024-55881-1","article-title":"Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage","volume":"14","author":"Boesl","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104833","article-title":"Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infection","volume":"25","author":"Spanos","year":"2022","journal-title":"iScience"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100113_bib258","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3390\/cells11162480","article-title":"Neuro-axonal damage and alteration of blood-brain barrier integrity in COVID-19 patients","volume":"11","author":"Zingaropoli","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100113_bib259","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154502","article-title":"Brain magnetic resonance imaging findings six months after critical COVID-19: a prospective cohort study","volume":"80","author":"Ollila","year":"2024","journal-title":"J Crit Care"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib260","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1038\/s41380-024-02554-0","article-title":"Long COVID: plasma levels of neurofilament light chain in mild COVID-19 patients with neurocognitive symptoms","volume":"29","author":"Gutman","year":"2024","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100113_bib261","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1085988","article-title":"Biomarkers in long COVID-19: a systematic review","volume":"10","author":"Lai","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.pharmr.2026.100113_bib262","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103512","article-title":"Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up","volume":"70","author":"Kanberg","year":"2021","journal-title":"EBiomedicine"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100113_bib263","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neurol.2020.10.001","article-title":"Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians","volume":"177","author":"Maury","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.pharmr.2026.100113_bib264","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.npbr.2020.05.008","article-title":"Neurological manifestations of COVID-19 and other coronaviruses: a systematic review","volume":"37","author":"Correia","year":"2020","journal-title":"Neurol Psychiatry Brain Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10072-021-05655-8","article-title":"Reversible conduction block of peroneal nerve associated with SARS-CoV-2","volume":"43","author":"Cioffi","year":"2022","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib266","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13024-024-00713-z","article-title":"GBA1 inactivation in oligodendrocytes affects myelination and induces neurodegenerative hallmarks and lipid dyshomeostasis in mice","volume":"19","author":"Gregorio","year":"2024","journal-title":"Mol Neurodegener"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib267","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.3390\/ijms22126469","article-title":"Inhibition of ceramide synthesis reduces \u03b1-synuclein proteinopathy in a cellular model of Parkinson\u2019s disease","volume":"22","author":"Mingione","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2026.100113_bib268","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100701","article-title":"Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells","volume":"296","author":"Carpinteiro","year":"2021","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib269","article-title":"Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells","volume":"1","author":"Carpinteiro","year":"2020","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10719-021-10025-9","article-title":"Systemic deficiency of GM1 ganglioside in Parkinson\u2019s disease tissues and its relation to the disease etiology","volume":"39","author":"Ledeen","year":"2022","journal-title":"Glycoconj J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib271","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/biomedicines11010209","article-title":"Age-related decline in gangliosides GM1 and GD1a in non-CNS tissues of normal mice: implications for peripheral symptoms of Parkinson\u2019s disease","volume":"11","author":"Chowdhury","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmr.2026.100113_bib272","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-3-031-12390-0_13","article-title":"Gangliosides in neurodegenerative diseases","volume":"29","author":"Ledeen","year":"2023","journal-title":"Adv Neurobiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib273","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/ijms25063323","article-title":"Alpha-synuclein and GM1 ganglioside co-localize in neuronal cytosol leading to inverse interaction-relevance to Parkinson\u2019s disease","volume":"25","author":"Kumar","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib274","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/biom12020173","article-title":"The key role of GM1 ganglioside in Parkinson\u2019s disease","volume":"12","author":"Chowdhury","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib275","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/2211-5463.13669","article-title":"Synthetic GM1 improves motor and memory dysfunctions in mice with monoallelic or biallelic disruption of GM3 synthase","volume":"13","author":"Chowdhury","year":"2023","journal-title":"FEBS Open Bio"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib276","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1038\/s41598-025-94148-1","article-title":"Preclinical assessment of a ganglioside-targeted therapy for Parkinson\u2019s disease with the first-in-class adaptive peptide AmyP53","volume":"15","author":"Fantini","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100113_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108797","article-title":"Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: target the target, not the arrow","volume":"267","author":"Fantini","year":"2025","journal-title":"Pharmacol Ther"},{"issue":"10393","key":"10.1016\/j.pharmr.2026.100113_bib278","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(23)00810-3","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"401","author":"Huang","year":"2023","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib279","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2215-0366(21)00084-5","article-title":"6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records","volume":"8","author":"Taquet","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pharmr.2026.100113_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101061","article-title":"Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases","volume":"39","author":"Taquet","year":"2021","journal-title":"EClinicalmedicine"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib281","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41593-020-00758-5","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2026.100113_bib282","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070379","article-title":"Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations","volume":"13","author":"Bonetto","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib283","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12974-021-02339-0","article-title":"Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients","volume":"19","author":"Jarius","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100113_bib284","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib285","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","article-title":"Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment","volume":"27","author":"Greene","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2026.100113_bib286","doi-asserted-by":"crossref","DOI":"10.1101\/2021.06.25.449905","article-title":"Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection","volume":"12","author":"Patterson","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100113_bib287","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/cells9112360","article-title":"COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain relevance","volume":"9","author":"Achar","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib288","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12987-022-00357-5","article-title":"Role of aging in blood-brain barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19","volume":"19","author":"Adesse","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib289","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-021-02210-2","article-title":"Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection","volume":"18","author":"Torices","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib290","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.stemcr.2022.01.015","article-title":"A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4","volume":"17","author":"Ma","year":"2022","journal-title":"Stem Cell Rep"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib291","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1350","article-title":"Endothelial cells are not productively infected by SARS-CoV-2","volume":"10","author":"Schimmel","year":"2021","journal-title":"Clin Transl Immunology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib292","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3390\/v15030745","article-title":"Human brain microvascular endothelial cells exposure to SARS-CoV-2 leads to inflammatory activation through NF-\u03baB non-canonical pathway and mitochondrial remodeling","volume":"15","author":"Motta","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib293","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12987-023-00479-4","article-title":"SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier","volume":"20","author":"St\u00fcdle","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharmr.2026.100113_bib294","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105131","article-title":"The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier","volume":"146","author":"Buzhdygan","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib295","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/jpm14020170","article-title":"Possible role of fibrinaloid microclots in postural orthostatic tachycardia syndrome (POTS): focus on long COVID","volume":"14","author":"Kell","year":"2024","journal-title":"J Pers Med"},{"key":"10.1016\/j.pharmr.2026.100113_bib296","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105561","article-title":"SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein","volume":"161","author":"Khaddaj-Mallat","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100113_bib297","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/cvr\/cvac143","article-title":"SARS-CoV-2 and vascular dysfunction: a growing role for pericytes","volume":"119","author":"McQuaid","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib298","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/brain\/awac481","article-title":"SARS-CoV-2 targets pericytes to restrict blood flow within the brain","volume":"146","author":"Miners","year":"2023","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib299","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00401-018-1885-0","article-title":"Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms","volume":"136","author":"Fekete","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"6477","key":"10.1016\/j.pharmr.2026.100113_bib300","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.aax6752","article-title":"Microglia monitor and protect neuronal function through specialized somatic purinergic junctions","volume":"367","author":"Cser\u00e9p","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib301","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuron.2020.11.007","article-title":"Shaping neuronal fate: functional heterogeneity of direct microglia-neuron interactions","volume":"109","author":"Cser\u00e9p","year":"2021","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib302","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211071","article-title":"Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions","volume":"219","author":"Cs\u00e1sz\u00e1r","year":"2022","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib303","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/mds.29116","article-title":"COVID-19 infection enhances susceptibility to oxidative stress-induced parkinsonism","volume":"37","author":"Smeyne","year":"2022","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib304","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3390\/v17050724","article-title":"The role of TDP-43 in SARS-CoV-2-related neurodegenerative changes","volume":"17","author":"Kim","year":"2025","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib305","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"7\u20138","key":"10.1016\/j.pharmr.2026.100113_bib306","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/21678421.2021.1883669","article-title":"Increased worsening of amyotrophic lateral sclerosis patients during Covid-19-related lockdown in France","volume":"22","author":"Esselin","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib307","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41398-022-02052-3","article-title":"COVID-19 and risk of neurodegenerative disorders: a Mendelian randomization study","volume":"12","author":"Li","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib308","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/mus.27373","article-title":"Infection rate, mortality and characteristics of veterans with amyotrophic lateral sclerosis with COVID-19","volume":"64","author":"Galea","year":"2021","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib309","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CND.0000000000000335","article-title":"Impact of COVID- 19 infection among hospitalized amyotrophic lateral sclerosis patients","volume":"22","author":"Digala","year":"2021","journal-title":"J Clin Neuromuscul Dis"},{"issue":"5\u20136","key":"10.1016\/j.pharmr.2026.100113_bib310","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1080\/21678421.2024.2336127","article-title":"Incidence of amyotrophic lateral sclerosis before and during the COVID-19 pandemic: evidence from an 8-year population-based study in Central Italy based on healthcare utilization databases","volume":"25","author":"Sopranzi","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib311","doi-asserted-by":"crossref","first-page":"234","DOI":"10.12968\/bjnn.2013.9.5.234","article-title":"Parkinson\u2019s disease: top 10 causes of sudden deterioration","volume":"9","author":"Magennis","year":"2013","journal-title":"Br J Neurosci Nurs"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib312","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/acn3.51616","article-title":"Impact of COVID-19 pandemic on patients with Parkinson\u2019s disease: a meta-analysis of 13,878 patients","volume":"9","author":"Mai","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib313","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1007\/s10072-022-06182-w","article-title":"SARS-CoV-2 vaccination, Parkinson\u2019s disease, and other movement disorders: case series and short literature review","volume":"43","author":"Imbalzano","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.pharmr.2026.100113_bib314","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.873925","article-title":"The indirect impact of COVID-19 on major clinical outcomes of people with Parkinson\u2019s disease or parkinsonism: a cohort study","volume":"13","author":"Vignatelli","year":"2022","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib315","doi-asserted-by":"crossref","DOI":"10.1002\/pri.1959","article-title":"Adherence rate, barriers to attend, safety and overall experience of a physical exercise program via telemonitoring during COVID-19 pandemic for individuals with Parkinson\u2019s disease: a feasibility study","volume":"27","author":"Torriani-Pasin","year":"2022","journal-title":"Physiother Res Int"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib316","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/brain\/awab094","article-title":"Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer\u2019s disease","volume":"144","author":"Asby","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2026.100113_bib317","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1742-2094-9-146","article-title":"Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia","volume":"9","author":"P\u00fcntener","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib318","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/jnnp.74.6.788","article-title":"Systemic infection, interleukin 1\u03b2, and cognitive decline in Alzheimer\u2019s disease","volume":"74","author":"Holmes","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib319","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1186\/s12889-023-16768-4","article-title":"The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink","volume":"23","author":"Lophatananon","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pharmr.2026.100113_bib320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-031-31978-5_28","article-title":"Infections, vaccinations, and risk of Alzheimer\u2019s disease (AD)\/dementia: probable involvement of reactivated herpes simplex virus Type 1","volume":"1423","author":"Itzhaki","year":"2023","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib321","first-page":"3271","article-title":"Herpes zoster vaccination reduces risk of dementia","volume":"35","author":"Lehrer","year":"2021","journal-title":"In vivo (Athens, Greece)"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib322","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s11357-024-01096-1","article-title":"Molecular cross-talk between long COVID-19 and Alzheimer\u2019s disease","volume":"46","author":"Pszczo\u0142owska","year":"2024","journal-title":"Geroscience"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100113_bib323","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/acn3.51688","article-title":"COVID-19 and the risk of Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and multiple sclerosis","volume":"9","author":"Zhang","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100113_bib324","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1532-5415.1975.tb00217.x","article-title":"The brain ganglioside pattern in presenile and senile dementia","volume":"23","author":"Op Den Velde","year":"1975","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib325","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1017\/S1041610296002736","article-title":"Membrane components separate early-onset Alzheimer\u2019s disease from senile dementia of the Alzheimer type","volume":"8","author":"Gottfries","year":"1996","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib326","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000063604","article-title":"Alzheimer disease\u2014effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme","volume":"14","author":"Svennerholm","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib327","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00401-024-02759-1","article-title":"Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer\u2019s disease","volume":"147","author":"Ollen-Bittle","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib328","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/acschemneuro.9b00532","article-title":"Spatial lipidomics reveals region and long chain base specific accumulations of monosialogangliosides in amyloid plaques in familial Alzheimer\u2019s disease mice (5xFAD) brain","volume":"11","author":"Kaya","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100113_bib329","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1021\/acs.analchem.3c05557","article-title":"Integrative single-plaque analysis reveals signature A\u03b2 and lipid profiles in the Alzheimer\u2019s brain","volume":"96","author":"Enzlein","year":"2024","journal-title":"Anal Chem"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib330","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.1616152114","article-title":"Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models","volume":"114","author":"Sardi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib331","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(23)00205-3","article-title":"Safety and efficacy of venglustat in GBA1-associated Parkinson\u2019s disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial","volume":"22","author":"Giladi","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib332","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41531-023-00595-w","article-title":"Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson\u2019s study","volume":"9","author":"Pachchek","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib333","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3390\/v13050808","article-title":"Inhibitors of protein glycosylation are active against the coronavirus severe acute respiratory syndrome coronavirus SARS-CoV-2","volume":"13","author":"Rajasekharan","year":"2021","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib334","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1073\/pnas.91.6.2235","article-title":"Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin","volume":"91","author":"Block","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100113_bib335","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1128\/jvi.70.10.7153-7160.1996","article-title":"N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure","volume":"70","author":"Fischer","year":"1996","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100113_bib336","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/QAD.0b013e32830efd96","article-title":"N-Butyldeoxynojirimycin is a broadly effective anti-HIV therapy significantly enhanced by targeted liposome delivery","volume":"22","author":"Pollock","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.pharmr.2026.100113_bib337","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106123","article-title":"Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals","volume":"237","author":"Brun","year":"2025","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib338","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2289007","article-title":"Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies","volume":"39","author":"Ferjancic","year":"2024","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100113_bib339","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1016\/j.pharmr.2026.100113_bib340","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces \u03b1-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib341","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.24790","article-title":"Ambroxol effects in glucocerebrosidase and \u03b1-synuclein transgenic mice","volume":"80","author":"Migdalska-Richards","year":"2016","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib342","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamaneurol.2019.4611","article-title":"Ambroxol for the treatment of patients with Parkinson disease with and without glucocerebrosidase gene mutations: a nonrandomized, noncontrolled trial","volume":"77","author":"Mullin","year":"2020","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib343","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: a pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib344","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20221927","article-title":"Polypharmacology of ambroxol in the treatment of COVID-19","volume":"43","author":"Wang","year":"2023","journal-title":"Biosci Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100113_bib345","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10895-023-03289-x","article-title":"High-throughput SARS-CoV-2 antiviral testing method using the Celigo image cytometer","volume":"34","author":"St Clair","year":"2024","journal-title":"J Fluoresc"},{"key":"10.1016\/j.pharmr.2026.100113_bib346","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1013038","article-title":"Ambroxol for the treatment of COVID-19 among hospitalized patients: a multicenter retrospective cohort study","volume":"13","author":"Lu","year":"2022","journal-title":"Front Microbiol"},{"issue":"36","key":"10.1016\/j.pharmr.2026.100113_bib347","doi-asserted-by":"crossref","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","article-title":"\u03b2-glucosidase 2 (GBA2) activity and imino sugar pharmacology","volume":"288","author":"Ridley","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100113_bib348","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110717","article-title":"Structural basis for inhibition of a GH116 \u03b2-glucosidase and its missense mutants by GBA2 inhibitors: crystallographic and quantum chemical study","volume":"384","author":"Meelua","year":"2023","journal-title":"Chem-Biol Interact"},{"key":"10.1016\/j.pharmr.2026.100113_bib349","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106917","article-title":"Sinbaglustat ameliorates disease pathology in a murine model of GM1 gangliosidosis without affecting CNS ganglioside levels","volume":"210","author":"Wannemacher","year":"2025","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2026.100113_bib350","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12408","article-title":"Projected increase in amyotrophic lateral sclerosis from 2015 to 2040","volume":"7","author":"Arthur","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100113_bib351","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pcad.2024.03.003","article-title":"Developing effective strategies to optimize physical activity and cardiorespiratory fitness in the long Covid population- The need for caution and objective assessment","volume":"83","author":"Faghy","year":"2024","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib352","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00421-024-05652-7","article-title":"Maximal oxygen uptake, pulmonary function and walking economy are not impaired in patients diagnosed with long COVID","volume":"125","author":"Berg","year":"2024","journal-title":"Eur J Appl Physiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib353","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.70009","article-title":"The metabolic and physiologic impairments underlying long COVID associated exercise intolerance","volume":"14","author":"Leitner","year":"2024","journal-title":"Pulm Circ"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100113_bib354","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29886","article-title":"Long-term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: a review of mechanisms involved","volume":"96","author":"Gay","year":"2024","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib355","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40798-024-00695-8","article-title":"Practical recommendations for exercise training in patients with long COVID with or without post-exertional malaise: a best practice proposal","volume":"10","author":"Gloeckl","year":"2024","journal-title":"Sports Med Open"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib356","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02152-2024","article-title":"Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitation","volume":"65","author":"Daynes","year":"2025","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100113_bib357","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/17482968.2011.601463","article-title":"Reduced exercise capacity in early-stage amyotrophic lateral sclerosis: role of skeletal muscle","volume":"13","author":"Mezzani","year":"2012","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1016\/j.pharmr.2026.100113_bib358","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1421566","article-title":"Physical exercise in amyotrophic lateral sclerosis: a potential co-adjuvant therapeutic option to counteract disease progression","volume":"12","author":"Fenili","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100113_bib359","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s40279-023-01846-9","article-title":"Metabolic signatures of performance in elite world tour professional male cyclists","volume":"53","author":"Nemkov","year":"2023","journal-title":"Sports Med"},{"key":"10.1016\/j.pharmr.2026.100113_bib360","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101454","article-title":"Lactate as a fulcrum of metabolism","volume":"35","author":"Brooks","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.pharmr.2026.100113_bib361","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.809485","article-title":"Chronic lactate exposure decreases mitochondrial function by inhibition of fatty acid uptake and cardiolipin alterations in neonatal rat cardiomyocytes","volume":"9","author":"San-Millan","year":"2022","journal-title":"Front Nutr"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100113_bib362","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3390\/biomedicines10051068","article-title":"Skeletal muscle and COVID-19: the potential involvement of bioactive sphingolipids","volume":"10","author":"Meacci","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100113_bib363","article-title":"SARS-CoV-2 uses Spike glycoprotein to control the host\u2019s anaerobic metabolism by inhibiting LDHB","volume":"278","author":"Monaco","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100113_bib364","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/17461391.2020.1761076","article-title":"Impact of sedentarism due to the COVID-19 home confinement on neuromuscular, cardiovascular and metabolic health: physiological and pathophysiological implications and recommendations for physical and nutritional countermeasures","volume":"21","author":"Narici","year":"2021","journal-title":"Eur J Sport Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100113_bib365","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/biomedicines13061371","article-title":"Deoxygenation trends and their multivariate association with self-reported fatigue in post-COVID syndrome","volume":"13","author":"Ladek","year":"2025","journal-title":"Biomedicines"}],"updated-by":[{"DOI":"10.1016\/j.pharmr.2026.100142","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T19:52:59Z","timestamp":1780861979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":365,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0031699726000013"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100113","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100113"}}